Description
Updated settlement calendar for the acquisition window takeover offer for PHARMAIDS PHARMACEUTICALS LIMITED with revised obligation download and settlement dates.
Summary
BSE has revised the settlement schedule for the Offer to Buy – Acquisition Window (Takeover) for PHARMAIDS PHARMACEUTICALS LIMITED. The takeover offer conducted from August 4-18, 2025 now has updated obligation download and settlement dates.
Key Points
- Settlement No: 2025067
- Bid Period: August 4, 2025 to August 18, 2025
- Revised Obligation Download Date: August 22, 2025
- Revised Settlement Date: August 25, 2025
- Demat shares must be delivered through Early Pay-in mechanism only
- Market Type “Takeover” and settlement No. 2025035 to be used in depository system
Regulatory Changes
No new regulatory changes - this is an administrative revision to previously announced takeover settlement schedule.
Compliance Requirements
- Members/Custodians must use Early Pay-in of Shares mechanism for demat share delivery
- Must specify Market Type “Takeover” and correct settlement number in depository system
- Refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges
- Follow revised guidelines for share acquisition through stock exchange
Important Dates
- August 22, 2025: Revised Obligation Download Date
- August 25, 2025: Revised Settlement Date
- Bid period already completed: August 4-18, 2025
Impact Assessment
Limited impact as this affects only participants in the PHARMAIDS PHARMACEUTICALS takeover offer. The revision provides additional time for settlement processing and ensures proper completion of the acquisition window process.
Impact Justification
Affects specific takeover settlement timeline for one company with clear compliance requirements